SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Outcomes in patients allocated to no-ASCT based on depth of response: initial results of a phase 2 trial assessing the impact of minimal residual disease (MRD) in patients with deferred ASCT (PADIMAC)

Yong, K; De Tute, R; De-Silva, D; Phillips, E; Counsell, N; Cavenagh, J; Roddie, C; Owen, R; Streetly, M; Schey, S; et al. Yong, K; De Tute, R; De-Silva, D; Phillips, E; Counsell, N; Cavenagh, J; Roddie, C; Owen, R; Streetly, M; Schey, S; Koh, M; Crowe, J; Quinn, M; D'Sa, S; Virchis, A; Cook, G; Crawley, C; Pratt, G; Cook, M; Ashcroft, J; Benjamin, R; Adedayo, T; Braganca, N; Lyons-Lewis, J; Smith, P; Clifton-Hadley, L; Rabin, N; Popat, R (2017) Outcomes in patients allocated to no-ASCT based on depth of response: initial results of a phase 2 trial assessing the impact of minimal residual disease (MRD) in patients with deferred ASCT (PADIMAC). HAEMATOLOGICA, 102. p. 266. ISSN 0390-6078
SGUL Authors: Koh, Mickey

[img]
Preview
PDF Published Version
Available under License ["licenses_description_publisher" not defined].

Download (1MB) | Preview
Item Type: Article
Additional Information: ©2017 by Ferrata-Storti Foundation/European Hematology Association
Keywords: Immunology, 1102 Cardiovascular Medicine And Haematology
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Academic Structure > Institute of Medical & Biomedical Education (IMBE) > Centre for Clinical Education (INMECE )
Journal or Publication Title: HAEMATOLOGICA
ISSN: 0390-6078
Related URLs:
Dates:
DateEvent
26 June 2017Published
Publisher License: Publisher's own licence
Web of Science ID: WOS:000404127002160
URI: https://openaccess.sgul.ac.uk/id/eprint/109745

Actions (login required)

Edit Item Edit Item